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ABSTRACT
 
The effect of Chlorhexidine 0.12% mouthrinse on
 
gingivitis end plague accuiiiulation in elderly patients was
 
studied. Subjects from three nursing homes were assigned
 
randomly to an experimental or placebo control group.
 
Following a thorough examination and screening, subjects in
 
the experimental group were given 0.12% CH while subjects in
 
the placebo group were given a 0.00% CH placebo mouthrinse.
 
Each group rinsed twice daily With 15 ml CH mouthrinse.
 
Oral hygiene status, measured by plagne score and a bleeding
 
score was evaluated after one, two and three months.
 
After the three months, results indicated that the
 
0.12% CH treatment had no significant effect on dental
 
plaque over a placebo treatment. These results suggest that
 
good oral hygiene alone is beneficial and the 0.12% CH
 
mouthrinse provides no additional benefit over the effects
 
of good oral hygiene alone.
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 CHAPTER I
 
INTRODUCTION
 
The positive correlation between the level of oral
 
cleanliness of patients and the health of their gingival
 
tissues has previously been the primary focus for the
 
control of caries and periodontal disease (Adams, 1970? De
 
La Rosa, 1975). To promote oral cleanliness, various oral
 
physiotherapy agents such as toothbrushes, floss,
 
interdental brushes and toothpick holders are employed by
 
patients. Success is highly dependant upon the motivation
 
and dexterity of the patient. A toothpaste with good anti-

plague properties which could supplement insufficient manual
 
tooth cleaning would therefore be welcomed. Several studies
 
have demonstrated that rinsing with a chlorhexidine solution
 
will significantly reduce the formation of dental plaque
 
(Loe and Schiott, 1970; Cunning and Loe, 1970). Such
 
mouthrinses have become especially useful to handicapped
 
patients and to patients receiving periodontal surgery
 
(Bonssvoll, 1978; Westfelt, et al., 1983).
 
Although brushing with a gel or toothpaste containing
 
chlorhexidine has been less extensively studied than
 
rinsing, reports demonstrate significant improvement
 
following either brushing with a chlorhexidine containing
 
. ■ 1 
 gel or rinsing with a mouthrinse, both with regard to plaque
 
scores (Bassiouny and Davies, 1975; CutresSf Brown and
 
Baker, 1977) and gingival inflammation scores (Bassiouny and
 
Davies, 1975). In addition, CH effects decrease the plaque
 
flora of the tongue, oral roucosa and saliva, as well as the
 
microbiota of dental plaque (Bain and Strahan, 1980).
 
The present study is intended to evaluate whether a
 
mouthrinse containing chlorhexidine could improve the
 
efficacy of mechanical plaque control procedures for
 
periodontal conditions in elderly patients.
 
This study will;
 
1.- Compare dental plaque scores and gingival
 
inflammation prevalence among patients in three nursing
 
homes.
 
2.- Assess any differences between the chlorhexidine
 
treated groups and the control (placebo) group, comparing
 
both groups before mechanical removal of plaque.
 
3.- Establish routine brushing and flossing techniques
 
for each patient.
 
4.— Determine the adequacy and effect of the
 
chlorhexidine mouthrinse.
 
Statement of Hvpotheses
 
Based on past studies and reports, significant
 
differences in plaque and bleeding scores are predicted for
 
treatment groups. A test of the null hypothesis will
 
include the following:
 
■ ■ " ' 2 
1.- There will be no significant differences in plaque
 
scores of patients receiving CH 0.12% and a placebo
 
mouthrinse during the study period.
 
2.- There will be no significant differences in
 
bleeding scores of patients receiving CH 0.12% and a placebo
 
mouthrinse during the study period.
 
3.- No significant differences in plaque scores will
 
be found between patients from different locations receiving
 
the CH 0.12% and a placebo mouthrinse during the study
 
period.
 
4.- No significant differences in bleeding scores will
 
be found between patients from different locations receiving
 
the CH 0.12% and a placebo mouthrinse during the study
 
period.
 
CHAPTER II
 
REVIEW OF THE LITERATURE
 
Recent studies conducted in Europe which evaluate the
 
effects of chlorhexidine inouthrinse programs over a period
 
of time under controlled conditions present positive
 
results. In addition, unique involvement of chlorhexidine
 
mouthrinse in the inhibition of plaque formation has been
 
recognized for many years in Canada, Denmark, Sweden and
 
Switzerland.
 
Lindhe et al. (1970) reported a significant reduction
 
of plaque and gingival inflaramation in a dog treated by
 
topical application of chlorhexidine. Confirming data were
 
reported by Harvey et al. (1983). In an investigation by
 
O'Neil (1976), it was concluded that chlorhexidine
 
mouthrinse was the probable cause for the reduction of
 
plaque and gingivitis in human subjects.
 
Cancro et al. (1972) noted that most studies evaluating
 
the effectiveness of chlorhexidine gluconate mouthrinse have
 
been done with adult populations who were using
 
chlorhexidine gel or toothpaste and were brushing and
 
flossing. Intraoral rinsing with chlorhexidine has been
 
shown to be an effective means of plaque control. The
 
long-term record of chlorhexidine rinsing seems particularly
 
good (Foulkes, 1973). There have been occasional reports of
 
side effects associated with chlorhexidine rinsing. In
 
1972, Fldtra, et al. published results of a study designed
 
to clinically assess the effects of chlorhexidine rinsing on
 
the oral health of 50 soldiers. Three of the soldiers
 
(developed niultiple soft tissue lesions that healed when the
 
rinsing stopped and did not reappear in two of the three
 
when rinsing was resumed.
 
Langebaek et al. (1976) conducted a study in Canada
 
using the crossover double-blind design to measure the
 
effect of 0.12% CH digluconate mouthrinse on healing after
 
gingivectomy. The healing process of gingivectomy improved
 
when the surgical area covered with Goe Pak. Healing was
 
promoted when chlorhexidine was used and subjects
 
maintained good oral hygiene.
 
Since the early investigations, much has been done.
 
Articles by Emilson et al. (1976), Bain et al. (1978), and
 
Tryggve et al. (1985) summarized the tremendous amount of
 
work which has been carried out in the United States and the
 
other countries directed toward determining the mechanism
 
underlying the chemical effectiveness of chlorhexidine gel
 
in plaque and gingivitis reduction. Subsequent studies
 
have shown that chlorhexidine mouthrinse is even more
 
beneficial than gel and dentifrices in controlling the
 
extent of dental plaque and gingivitis in an adult
 
population.
 
Subsequent researchers reached similar conclusions and
 
agreed in general with prior studies (Sturzenberger et al.,
 
1986; Grossman et al., 1986). These researchers stressed
 
the fact that "a more standardized approach will need to be
 
adopted in order to ensure that data from a series of
 
coordinated studies are compa"til3l®-"
 
It is interesting to note the statistical information
 
in evaluating the effects of chlorhexidine mouthrinse•
 
Brushing with chlorhexidine gel over a twelve^week period
 
showed significant changes for both oral hygiene level and
 
the gingival inflammation in a group of maintenance care
 
patients with poor oral hygiene (Tryggve et al., 1985).
 
Brown staining of the teeth has so far been the only
 
adverse effect that has prevented a more extensive long-term
 
use of CH. This Stain can be removed with routine polishing
 
procedures. High concentrations of 2% CH digluconate taken
 
over long periods of time may cause burning sensations,
 
dryness and desquamation of the oral tissues (Eriksen et
 
al., 1973). At the end of six months, statistically
 
significant differences were found between the two groups:
 
less gingivitis, gingival bleeding and plaque accumulation
 
were obseryed in the test group as compared to the placebo
 
group. No significant differences in adverse oral soft
 
tissue effects were observed between the two groups.
 
However, researchers conducted a study to test the
 
reduction in plaque and gingivitis effect of chlorhexidine
 
mouthrinse in "a population of adult subjects receiving
 
systematic oral health care and prevention and control of
 
gingivitis at home" (Catherine et al., 1980). The results
 
of this study indicated statistically significant
 
differences between the adult subjects participating in the
 
chlorhexidine mouthrinse program and those in the control
 
group.
 
Product
 
Chlorhexidine is a chlorophenyl biguanide with broad
 
antimicirobial activity. CH gluconate, the most suitable
 
salt, has been used in preparatibn of the patient as
 
sutgical scrub and as a hand wash for health care petsonnel
 
(AMA, 1983). It has also been used as a preservative for
 
opthalmic products and has been used internally at a 0.2%
 
concentration in the peritoneal cavity and bladder (Case,
 
1977).
 
In dentistry, CH has been investigated as a plaque
 
control agent for control of smooth surface caries (Low, Von
 
Der Fehr, and Rindom, 1972) and as a denture disinfectant
 
particularly in regard to Candida Albicans (Budtz and Loe,
 
1972). CH is the most extensively tested agent with
 
consistently positive results. CH appears both to inhibit
 
the formation of plaque and to control plaque already
 
present. Although CH has even shown some degree of
 
effectiveness in the absence of hoiae care measures, its use
 
should only be considered to be adjunctive in nature. CH
 
should never be considered as a substitute for thorough
 
initial therapy and the establishment of the best
 
conventional home care possible.
 
Adverse Effects
 
The adverse effects of CH in a mouthrinse appear to be
 
minimal, widespread use over many years, especially in
 
Europ®/ has shown a remarkable safety record. CH is poorly
 
absorbed from the GI tract so that even if some is
 
inadvertently swallowed, the chance of a systemic effect is
 
essentially negligible. CH does not appear to penetrate
 
intact gingiva, but may have toxic effects on exposed
 
subepithelial cells (Tonelli, Hume and Matsunaga, 1982).
 
No significant adverse clinical effects relating to this
 
have been reported. However, poorly defined desguamative
 
lesions have sometimes followed the use of a CH mouthrinse.
 
Surprisingly, an increase in calculus formation may be
 
observed. Dryness and burning sensations have sometimes
 
followed the use of CH rinses.
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 Potential Benefits
 
A CH Gontaining mouthrinse, Peridex, has now been
 
approved by the Food and Drug Administration for use in the
 
United States. Although there appears to be little question
 
of the effectiveness and relative safety of mouthrinse
 
containing 0.12% CH, each specific product must be approved
 
on its own merits.
 
In 1986, sturzenberger et al. presented a report of a
 
six-month clinical evaluation of 0.12% CH gluconate
 
mouthrinse. They found that the beneficial effects of a
 
prophylaxis against gingivitis were maintained over a six-

month test period by the CH rinse, but not by a placebo
 
rinse. Also in 1986, Grossman et al. published a report on
 
a six—month trial of the effects of the same 0.12% CH
 
gluconate mouthrinse on plaque and gingivitis. The 430
 
adult subjects were instructed to rinse twice daily for 30
 
seconds with 15 ml of the CH gluconate mouthrinse. Their
 
usual home care procedures were to continue. After three
 
and six months of use, the chlorhexidine group had
 
significantly less gingivitis and gingival bleeding than
 
did the placebo group. No significant differences in
 
adverse oral soft tissue effects were observed between the
 
two groups. It was concluded that a 0.12% CH gluconate
 
mouthrinse can provide an important adjunct to the
 
prevention and control of gingivitis when used with regular
 
personal oral hygiene procedures and professional care.
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CHAPTER III
 
METHODS AND PROCEDURES
 
This study examined the value of the use of
 
Chlorhexidine mouthrinse in plaque control in elderly
 
patients in California, information relevant to the study
 
was collected simultaneously from three nursing homes: two
 
in Indio and one in San Bernardino.
 
Defihition of Terms
 
The following words are defined to ensure a clear
 
Understanding of the study:
 
Plague Scores: The presence of plaque was disclosed by a 15
 
second rinse With a standard red dye (Phloxine B Red #28)
 
gel. The quantification of plaque on six surfaces of each
 
natural tooth, (mesio-facial, facial, disto-facial, disto­
lingual, lingual and mesio-lingual) was recorded by a
 
dicotamous scoring which indicated either presence or
 
absence of plaque. Plaque was measured as being present at
 
gingival margin when it stained dark with Phloxine
 
disclosing gel and also was easily removed with the side of
 
a probe (Figure 1).
 
The plaque score for the entire mouth was determined
 
by dividing the total number of tooth surfaces identified as
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having plague by the numbeir of sites examined foir each
 
individual patient. Example: 40 x 100 — 23% Plaque 
168 
score. 
Bleeding Scores: The bleeding score was determined after
 
probing of the six defined sites of the tooth and then
 
evaluating for presence or absence of bleeding for each
 
site. By using periodontal probe with Michigan markings
 
(MI, Marquis Dental) the probe was directed at the mesio­
buccal, buccal, disto-buccal, disto-lingual, lingual and
 
mesio-lingual margins of the gingiva, resulting in a total
 
of six scores per tooth. The bleeding score for the entire
 
mouth was determined by dividing the total number of sites
 
that exibited bleeding by the number of sites probed for
 
each individual patient.
 
Example 10 x 100 = 5% Bleeding score.
 
168
 
Chlorhexidine 0.12% mouthrinse: Chlorhexidine was
 
originally introduced into dentistry to facilitate post-

surgical wound healing and for disinfecting root canals.
 
The initial report of CH's antiplaque property was made by
 
Schroeder in 1962. In 1970, Loe and Schiott reported the
 
prevention of gingivitis (inflamation of the gums) with use
 
of 0.20% CH digluconate applied twice daily (Loe et al.,
 
1973).
 
Although CH is widely used in Europe in such countries
 
as Denmark, Great Britain, Sweden, and Switzerland for
 
dental treatment, it was not approved by the FDA for routine
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dental use in the United States until 1986.
 
A considerable number of studies show that use of 0.12%
 
GH has decreased plaque accumulation and diminished
 
gingivitis. CH 0.12% mouthrinse is of particular value for
 
patients in convalescent hospitals and people with physical
 
or mental handicaps. Since improper plaque removal is
 
conducive to caries and periodontal disease, an effective
 
chemical may be beneficial for those patients.
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#29 Lingual view of #30
 
scoring of pla<^e on #30
 
B
B
 
M MB B DB D M MB B DB
 
ML ML DL 
V ✓ 
Figure 1.- Index for measuring plaque scores
 
(V) Check indicates presence of stained plaque in
 
boxes corresponding to surfaces with plaque MB, ML, DB,
 
DL, B, L«
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Limitations
 
The Gollection of data was limited to the study of two
 
types of recorded data; plaque and bleedinq scores. The
 
data was also limited to the forty two patients, ranging in
 
aqe froin 50—80 years, whose dental examination records Were
 
available. All scoring of those patients was performed by
 
one examiner. It was difficult to examine the oral hygiene
 
practice in those patients with physical or mental
 
disabilities.
 
Studv Population and Sampling Technique
 
The population sampled in this study consisted of fifty
 
elderly patients. Their ages ranged from 50 to 80 years,
 
with a mean age of 65, Eight males and forty two females
 
were included. Two nursing homes in Indio, CA (Del Rosa)
 
were selected at random from a large sample of convalescent
 
hospitals. The subjects were selected by the nursing staff
 
of each nursing home based on the patients' past history of
 
good oral hygiene and no serious history of health problems.
 
The majority of patients at all three sites had no
 
treatment needs and had neither obvious gum disease nor
 
obvious decay in their teeth. During the course of the
 
study, four subjects died and four others did not complete
 
the program, reducing the number of subjects for analyses
 
to forty two. In addition, a baseline examination was
 
conducted at the beginning of the study to ensure an
 
adequate number of teeth, at least 8-10 per subject, and to
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 evaluate present oral hygiene status.
 
An additional refined data analysis was conducted on a
 
smaller sample size of 25 siibjects* Based on baseline
 
scores, subjects were selected for this data analysis if
 
they had a plaque score of between 20 and 40. These are
 
indicated as either (a) for CH placebo or (b) 0.12% CH
 
treatment in Appendix A-3, A-4, A-5, (m = mechanical
 
cleaning). The smaller sample size was a more accurate
 
representation of the population under study.
 
study Design
 
Subjects were randomly assigned to either an
 
experimental group (Group A, fl = 25) or a placebo control
 
group (Group B, |i = 25). For Group A, the mouthrinse
 
contained a 0.12% CH gluconate mouthrinse. For Group B the
 
solution was a placebo made from ethyl alcohol, glycerine,
 
distilled water and food coloring, which matched the CH
 
solution in taste, appearance and texture. The mouthrinse
 
was supplied in pint bottles. Plastic measuring cups and
 
30-second timers were provided to assist in the dispensation
 
and application of the mouthrinse. In order to assure a
 
double-blind desigjn, neither the nursing staff members nor
 
the investigator knew which group the subjects had been
 
assigned to. Both solutions were coded by a periodontist
 
who placed the coded number with the group assignment of
 
each subject in a sealed envelope to ensure that group
 
assignment was not known to the treatment staff or the
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subjects.
 
After signing a written consent form (Appendix A—1)
 
the subject was provided with oral hygiene instruction. The
 
program consisted of a standard oral hygiene program
 
including disclosure of plague and instruction in the use of
 
a mouthrinse. The examiner spent four days a week assisting
 
in the dispensing, application, and use of the mouthrinses.
 
Subjects spent one hour daily in improving oral hygiene
 
habits. The mean cost of the program was five dollars per
 
patient per month. Including the baseline examination, the
 
final cost was twenty dollars per patient.
 
Measures
 
Three measures (plaque, gingival bleeding, and oral
 
soft tissue effects) were used in this study. The presence
 
of plaque was discovered after staining with a 15 second
 
rinse with a disclosing gel (Phloxine B Red #28). Presence
 
of plaque was recorded if an area of clearly stained plaque
 
was present along the gingival margin and if plaque could be
 
removed with the side of a probe (Figure 1). This
 
assessment for plaque was made at each of the following six
 
tooth surfaces of each natural tooth: mesio-facial, facial,
 
disto-facial, disto-lingual, lingual and mesio-lingual. The
 
percentage of tooth surfaces with plaque out of the total
 
number of examined tooth surfaces was calculated.
 
The gingival bleeding score was determined by using a
 
periodontal probe with Michigan markings (MI, Marquis
 
'■ ■ ■ .I6v ■ 
Dental) to probe the mesio.facial, facial, disto-facial,
 
disto'lingual, lingual and mesio-lingual surfaces on each
 
tooth surface of the gingiva resulting in a total of six
 
scores per tooth. During probing of each of the six sites
 
of the teeth, the probe was gently moved twice in the apical
 
direction to secure finding the base of the pocket. After
 
removal of the probe, the gingival margin was examined and
 
the presence of bleeding was recorded. If hemorrhage was
 
noted subsequent to the probing, a positive score was
 
recorded.
 
Oral soft tissue effects were also evaluated. To
 
monitor oral soft tissue health, a visual tactile
 
examination of the oral mucosa was conducted to detect
 
pathoses which could possibly be attributed to Chlorhexidine
 
uses (V. A. Segreto et al., 1986).
 
Procedures
 
Both the experimental (group A) and the control or
 
placebo (group B) subjects received identical, standardized
 
oral hygiene instruction about the use of a soft toothbrush
 
and dental floss with the mouthrinse twice daily for thirty
 
seconds.
 
Subjects in both the experimental (Group A) and placebo
 
(Group B) groups were evaluated at baseline (day 0) and at
 
four weeks, eight weeks and twelve weeks in the study
 
Each treatment period lasted for four weeks during
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which the subject rinsed twice daily for thirty (30)
 
seconds with 15 ml of the mouthrinse. At each examination,
 
the examiner used portable equipment, perio probes, and
 
mouth mirrors, examined the patients and recorded plaque and
 
bleeding scores.
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CHAPTER IV
 
RESULTS
 
Twenty five experimental (Group A) and twenty five
 
control (Group B) subjects were solicited from the three
 
nursing homes for the study. Of the fifty subjects who
 
enrolled in this study, forty two completed three months of
 
mouthrinse use. The eight dropouts were patients who either
 
died or could not meet examination schedules.
 
Each subject received an evaluation of plaque and
 
bleeding indices (baseline scores) prior to receiving either
 
the placebo or 0.12% CH mouthrinse (Table 1, Figure 1).
 
Initial evaluations by the investigator indicated
 
observable differences in oral hygiene prior to start of the
 
study. The results of an analysis of variance shows
 
significant differences (p<.001) in plaque and bleeding
 
(p<,002) scores of patients at baseline that was dependent
 
upon location. Subjects in Desert Palm nursing home had
 
significantly higher (worse) scores for both plaque and
 
bleeding than patients at both Mul Care and Del Rosa.
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Table 1. Mean plaque and bleeding scores by location
 
Care, Del Rosa and Desert Palm nursing homes) at Baseline
 
Locations Plaque scores (a) Bleeding scores (b)
 
Mean + S D , Mean + S D
 
Desert Palm 37.230 +9.86 17.615 +7.85
 
Del Rosa 27.692 + 7.57 7.846 + 5.97
 
Mul care 25.500+ 9.25 9.875 + 7.02
 
a. Sig of f, p<.001
 
b, Sig of f, p<.002
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Figure la. Mean Plaque scores and Bleeding scores by
 
locations (Desert Palm, Mul Care and Del Rosa nursing
 
homes) at Baseline.
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Baseline plaque and bleeding scores are shown in Table
 
II and represented in Figure 2. An analysis of the variance
 
showed no significant differences in plaque and bleeding
 
scores of patients at the start of the study that was
 
dependent upon the group (A, treatment; (B), placebo) to
 
which they had been randomly assigned.
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 Table IT. Mean Plaque and Bleeding scores by groups 0.12%
 
Chlorhexidine vs. Chlorhexidine placebo at baseline.
 
Baseline Scores
 
Desert Palm Del Rosa Mul Care
 
M 0.12% CH Placebo 0.12% OH Placebo 0.12% CH Placebo
 
Plaque 39.666 35.142 28.142 27.166 31.750 19.250
 
Bleeding 18.000 17.285 6.142 9.833 13.375 6.375
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Figure 2. Mean Plaque and Bleeding scores by groups
 
0.12% CH vs. CH placebo at baseline.
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Plague and bleeding at baseline, one, two, and three
 
months are shown in Table III and represented in Figure 3
 
An analysis of the variance yielded a significant f
 
(F (1,36) =12.3, p<.001) for changes in both plague and
 
bleeding (F (1,36 = 1.57, p<.002) scores for subjects.
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Table III. Comparison of ANOVA in Plaque and Bleeding scores over three
 
months time.
 
One month Two months	 Three months
 
F df sig f F df sig f F df sig f
 
to
 
cr^	 Plaque 12.3 (1,36) P<.0013 41.15 (1,36) P<.0001 76.13 (1,36) P<.0001
 
Scores
 
Bleeding 1.57 (1,36) P<.2176 6.74 (1,36) P<0.0136 29.11 (1,36) P<.0001
 
Scores
 
There are significant changes in Plaque (p<.001) and bleeding (p<.002)
 
scores for both experimental and control groups over three months time.
 
(0
 
o
 
u
 
o
 
o
 
CO
 
c
 
•H
 
0)
 
(U
 
iH
 
P3
 
TJ
 
cd
 
(D
 
SJ
 
0^
 
«d
 
(H
 
PL4
 
*W
 
O
 
cd
 
4J
 
O
 
c
 
rd
 
0)
 
s:
 
Plaque:
 
Bleeding:0-O
 
20
 
One month Two months Three months
 
Length of study (3 months)
 
Figure 3, Mean Plaque and Bleeding scores over time.
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Plague scores at baseline, one, two, and three months
 
for the experimental and placebo groups are shown in Table
 
IV and represented in Figure 4. An analysis of the variance
 
yielded no significant differences in plague scores over the
 
three month study period that was dependent on receiving a
 
0.12% CH mouthrinse or a placebo solution.
 
TeOale IV. Comparison of treatment groups over three months
 
time for mean Plague scores.
 
Group Mean Plague Scores
 
Baseline One month Two months Three months
 
CH Placebo 26.81 21.24 18.67 15.05
 
0.12% CH 32.81 27.48 20.19 16.90
 
Baseline vs. 1 month F (1,36) = .06, p<.80
 
Baseline vs. 2 months F (1,36) — 1.51, p<.20
 
Baseline vs. 3 months F (1,36) =1.38, p<.20
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Figure 4. Plaque scores schedule of 0.12% CH vs. CH
 
Placebo over time (3 months).
 
There are no significant differences between plaque
 
scores of experimental and control groups over time (3
 
months).
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Bleeding scoires at baseline, one, two, and three months
 
for the experimental and placebo groups are shown in Tcible V
 
and represented in Figure 5. An analysis of the variance
 
yielded no significant difference in bleeding scores over
 
the three month study period that was dependent on receiving
 
a 0.12% CH mouthrinse or a CH placebo solution.
 
Table V. Comparison of trea^ent groups over three months
 
time for mean Bleeding scores.
 
Group Mean Bleeding Scores
 
Baseline One month Two months Three months
 
CH Placebo 11.00 11.52 9.62 6.95
 
0.12% CH 12.29 14.57 9.43 6.71
 
Baseline vS. one month F (1,36) as o.68, p<.400
 
Baseline vs. two months F (1,36) ® 0.90, p<.35
 
Baseline vs. three months F (1.36) = 0.69^ p<.40
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Figure 5. Bleeding scores schedule of 0.12% CH vs. CH
 
placebo over time (3 months).
 
There are ho significant differences between, bleeding
 
scores of experimental and control groups over time (3
 
months).
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Refined Da-ta Analysis
 
Because of the wide variance in baseline plaque scores,
 
ranging from 6 to 63, a refined data analysis was used.
 
Only patients with plaque scores between 20 and 40 were
 
included. This eliminated stibjects with extreme scores.
 
Refined analysis followed the basic application of ANOVA and
 
student's t tests to the deta.
 
Statistical analysis of plaque at baseline for three
 
convalescent hospitals was established with a sample size of
 
25 (combined placebo and CH groups).
 
Mean plaque at baseline in Desert Palm was 31.375
 
Mean plaque at baseline in Del Rosa was 30.181
 
Mean plaque at baseline in Mul care was 27.000
 
Comparison plac^e P (Placebo or control) 1 month vs. 3
 
months was noted. Significance was found between the
 
placebo group in the amount of plaque at one month vs. three
 
months, F (1,26 =71.217^ p<.001. There were also
 
significant differences between the CH group in the amount
 
of plaque at one month vs. three monthS/ F (1,20) = 18.949,
 
p<.001.
 
Therefore, the improvement was due to treatment and
 
mechanical brushing, but no significant difference was found
 
between CH and Placebo groups:
 
Baseline: At baseline, there was no significant difference
 
in plaque scores between the experimental group and the
 
control group, F(1,23) = .056, p<.97.
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O n e  m o n t h  v s .  t h r e e  m o n t h s :  A t  o n e  m o n t h  v s .  t h r e e  m o n t h s , 
  
n o  m a i n  e f f e c t s  w e r e  f o u n d  b e t w e e n  C H  a n d  P l a c e b o  g r o u p s , 
  
F  ( 1 , 2 6 )  =  6 . 4 1 1 ,  p < . 9 4 1 . 
  
A l t h o u g h  i m p r o v e d  s c o r e s  w e r e  n o t e d  f o r  b o t h  C H  a n d 
  
P l a c e b o ,  t h e  C H  a n d  P l a c e b o  g r o u p s  d i d  n o t  d i v e r g e 
  
s i g n i f i c a n t l y  f r o m  e a c h  o t h e r . 
  
3 3 
  
CHAPTER V
 
DISCUSSION
 
This study was conducted to evaluate the gingival
 
bleeding and plaque scores of elderly patients at three
 
nursing homes and to assess the effectiyeness of 0.12% CH
 
mputhrinse during three months of twice daily use. Side
 
effects such as oral pathoses, calculus formation and tooth
 
stain were also monitored.
 
There were no significant differences in bleeding
 
between the baseline and time 1 (one month) measurements (F
 
(1,36) - 1.57, p<.217). There was a significant difference
 
from the baseline to time 2 (two months after baseline) (F
 
(1,36) =6.74, p<.013), as well as a significant difference
 
from the baseline to time 3 (three months after) (F (1,36) =
 
29.11, p<.0001).
 
Measurement showed a significant decrease in plaque at
 
the one month (F (1,36) = 12.13, p<.001) as well as
 
significant differences from the baseline and the two months
 
(F (1,36) = 41.15, p<.0001), and baseline to the three
 
months (F (1,36) = 76.13, p<.0001).
 
However, these decreases in both bleeding and plaque
 
scores were seen in both groups, control and experimental.
 
No significant differences were found between the CH
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treatment group and the placebo group in the amount of
 
plague and bleeding, (CH mean = 24.35, p<.129) at either one
 
month, two months or three months. Significant differences
 
were found between the nursing home locations and of plaque
 
and bleeding scores (F (2,36 = 8.16, p<.001). It seemed
 
that these differences were due to the lower level of oral
 
hygiene in patients at Desert Palm whose plaque score (mean
 
= 30.42) was higher than the other two locations (Del Rosa,
 
mean =18.10, Mul Care, mean =19.35).
 
There were no significant differences between the CH
 
and placebo over time. Differences did exist at the study
 
start however, in plaque that were dependant on location. At
 
the start plaque was different at the nursing homes. Desert
 
Palm, Mul Care and Del Rosa.
 
The mean bleeding scores of both groups were increased
 
in the first month. Ten subjects were sick and unable to
 
take care of their oral hygiene (Figures 1 & 2). Otherwise,
 
the 0.12% CH group showed significant improvements (83%) in
 
both bleeding and plaque scores at the end of the third
 
month. The placebo group showed (67%) improvement in
 
bleeding and plaque.
 
This study did not demonstrate significant effect of
 
0.12% CH treatment. This could possibly be due to the types
 
of patients used in this study. The 0.12% CH mouthrinse did
 
not work in older patients who were less mentally and
 
physically active and who may not have been able to fully
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subjects, there were differences in taste between CH
 
raouthrinse in comparison to the placebo. In fact, the 0.12%
 
GH mouthrinse produced a slight burning sensation in the
 
mouth, so the subjects did not like the mouthrinse compared
 
to the placebo subjects. They suggested one could expect
 
better compliance with mouthrinse containing less than 0.12%
 
CH. Therefore, they may not have followed the instructions
 
for using the mouthrinse sufficient for 0.12% CH to have had
 
a successful impact on plaque and gingival bleeding.
 
Several past studies have demonstrated that rinsing
 
with a 0.12% CH solution will significantly reduce the
 
formation of dental plaque (Loe and Schiott, 1970; Cunning
 
and Loe, 1973). Greenstein (1984) discussed the evaluation
 
of gingival bleeding as not only.more diagnostic, but also
 
reflective of histological^ clinical and bacterialogical
 
tissue alterations. Researchers also state "the absence of
 
bleeding in previously inflammed tissue can be interpreted
 
that there has been an improvement on the periodontal
 
status" (Greenstein, 1984).
 
In addition, 0.12% CH has been shown to reduce aerobes,
 
anaerobes, anaerobes and actinomyces by 54-97%.
 
Consequently, the reduced gingivitis may be partly due to
 
the reduced pathogenity of the plaque (Briner et al.,
 
1968a).
 
Articles by Loe et al., (1976) and Lange et al., (1982)
 
showed reduction in gingivitis even though there was an
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showed reduction in gingivitis even though there was an
 
increase in supragingival calculus. In this study, the
 
examiner observed the subjects' supragingival calculus in
 
the 0.12% CH treated group. There were no significant
 
increase in supragingival calculus, but there was a
 
significant decrease in gingivitis. There was also no sign
 
of extrinsic tooth staining in the 0.12% CH treated group.
 
This may be due to low levels of compliance. No significant
 
differences in adverse oral soft tissue effects were noted
 
between the two groups.
 
The results of this study suggest that oral hygiene is
 
beneficial. The improvements in bleeding and plaque scores
 
were possibly due to patients being influenced by the
 
attention of the dental professionals who cared for them.
 
Motivational education is necessary to produce lasting
 
behavioral changes. A good plaque control program,
 
effectively maintained in nursing homes, is important for
 
good oral care.
 
The design of this study does not allow separate
 
interpretations of the effect of the improved oral hygiene
 
and the effectiveness of the mouthrinse. Only one month of
 
observation was Scheduled between the start of the oral
 
hygiene and the first treatment. During this month, ten
 
patients were sick, so the plaque and bleeding scores were
 
affected in the treatment.
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Recommendations
 
Based on the experiences of this research process^ the
 
following recommendations are suggested for future studies
 
of Chlorhexidine mouthrinse:
 
1. 	 It would be useful to have dental health records
 
available for each subject in order to make a more
 
accurate evaluation of their dental health;
 
2. 	 Patients should be individually scored on their
 
pre-^test oral hygiene conditions and divided into
 
groups with equal plaque scores (high plaque, low
 
plaque) from which random division into test and
 
control groups would be made;
 
3. 	 Since reliability of scoring is compromised with
 
one scorer, a team of scorers should be trained,
 
and their techniques standardized prior to study
 
Start;
 
4. 	 since this study clearly demonstrated the need for
 
oral hygiene in nursing home patients, future
 
studies might address different application
 
procedures to increase compliance by elderly
 
patients;
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5. Studies might be conducted in dental clinics or
 
dental schools instead of the convalescent
 
hospitals to increase reliability of Chlorhexidine
 
application.
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CHAPTER VI
 
SXJMMARY AND CONCLUSIONS
 
Forty two patients from Del Rosa, Desert Palm and Mul
 
Care convalescent hospitals were involved in a study of the
 
effect of 0.12% CH mouthrinse in producing changes in their
 
oral hygiene habits as well as the reduction in plaque and
 
gingivitis. Subjects were divided into a control and an
 
experimental group. The oral hygiene effectiveness of the
 
subjects was measured with a plaque score and bleeding score
 
at baseline, one, two and three months after using 0.12% CH
 
mouthrinse.
 
A statistical analysis was done to determine the effect
 
of 0.12% CH. There was no significant difference between
 
the treatment group and placebo group. There were
 
significant improvements in the oral hygiene of the elderly
 
in both groups. The results indicated that there was a
 
significant difference in the gingival bleeding measured
 
from the baseline measurement at time 2 (two months after
 
baseline) and time 3 (three months after). There were also
 
significant differences in plaque from the baseline and "two
 
months after" and "three months after."
 
The following conclusions were drawn;
 
1) oral hygiene is beneficial,
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2) patient motivation had an influence in the reduction
 
of plaque and bleeding scores when used in conjunction with
 
personal and professional oral hygiene procedures,
 
3) the 0.12% CH mouthrinse did not seem to have any
 
clinical benefits to those elderly patients.
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APPENDIX
 
42
 
CONSENT TO PARTICIPATE IN STUDY
 
I, ' , do hereby agree to be a
 
participant in a three (3) month study period measuring the
 
effects of tooth brushing and flossing versus the same tooth
 
brushing and flossing technique in conjunction with the use
 
of a predetermined amount of chlorhexidine (CH) mouth-

rinse.
 
I have been informed that I will receive an initial prophy
 
laxis treatment, including scaling, to establish equal
 
dental hygiene cohditions for both study groups. I will be
 
given the tooth brushing and flossing instructions necessary
 
to participate in this study, and I will be given periodic
 
oral examinations to determine the results of this care. I
 
am aware that I may or may not be in the group receiving the
 
mouthrinse supplements
 
CH was originally introdUGed into dentistry to inhibit the
 
formation of plaque and to control plaque already present
 
and lower the incidence of gingivitis, (both inflammation
 
and bleeding gums).
 
side effects of CH .12% are relatively minimal, although it
 
has a bitter taste, and with chronic use a brown
 
discoloration may occur. This stain can b® removed with
 
routine polishing procedures. High concentrations of CH.2%
 
taken over long periods of time cause burning sensations,
 
and/or dryness of the oral tissues.
 
If I am in the group using the placebo solution mouthrinse,
 
I will have access to treatment after the study. I will be
 
assigned a code number. This number, not my name, will be
 
used for recording at all four examination test periods.
 
I may withdraw from participation in this study for any
 
reason and at any time. My participation is voluntary and
 
my willingness or lack thereof will not affect the care I am
 
receiving.
 
SIGNATURE DATE
 
WITNESS date
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FORM II. LETTER CONCERNING DENTAL CARE
 
December 18, 1987
 
To: Tri County Dental Hygiene Association
 
I have currently been observing the diental health care
 
of elderly patients as part of my Master's thesis on 0.12%
 
CH mouthrinse. As health care providers. Dental Hygienists
 
or Dental Professionals have an obligation to help these
 
patients improve oral health care.
 
For this reason^ and based 6n my awareness of the
 
Dental Public Health needs of elderly patients in
 
convalescent hospitals in California, I would propose a
 
program to use RDHs or Dental Hygienist students to:
 
1. Assist patients in Dental Health Education and to
 
make dental knowledge and services available to them.
 
2. Help reduce periodontal disease and dental caries
 
by improving the oral health care of these patients.
 
Measurable improvements will result from in-service
 
programs conducted by Dental Professionals practicing dental
 
health education in convalescent hospitals. My observation,
 
based on my study of the effectiveness of 0.12% CH
 
mouthrinse in three California nursing homes, is that
 
current programs for oral hygiene and plaque control are
 
very poor. More and better attention to oral health care is
 
needed. Instruction and continued follow-up supervision
 
would be effective in reducing plaque and bleeding scores in
 
these patients.
 
I ask your consideration and cooperation in providing
 
highly skilled Hygienists and Dental Professionals to
 
contribute to the Preventive Dentistry Program and the
 
control and prevention of periodontal disease in nursing
 
home patients.
 
Sincerely,
 
Thanh T. Nguyen, R.D.H.
 
TtN:cw
 
cc: Tri County DHA
 
Dr. Judson Klooster, Dean, School of Dentistry,
 
Loma Linda University
 
Ms. Joni Self, Chairperson, Dental Hygiene Department
 
School of Dentistry, Loma Linda University.
 
Dr. Clifton Dummett, U.S.C.
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DESERT PALM 
Characteristics 
Number Sex 
F Good oral hygiene, nice patient, 
cooperative 
2® F super patient, good OH, interested in 
mouthrinse 
3 F Emotional person, cried easily, good OH, 
cooperative 
4^ F Mild mental problems, good patient, good 
OH 
5 M Mild mental and physical problems, nice 
patient, fair OH 
6® F Quiet person, poor OH, cooperative, 
tried to improve her oral hygiene 
7^ F Fair OH, sometimes cooperative, 
gingivitis 
8 F Fair OH, sometimes difficult to work 
with 
9®m F Physical disability, poor OH, 
10® F Physical disability, poor OH, difficult 
to work with 
11 F Mental problems, very hard to work with, 
relied on her relative's assistance, 
fair OH 
12m M Very poor OH, sick all the time, 
outwardly cooperative but did not use 
mouthrinse, gingivitis 
13^m M Mental problems, sick in the 1st month, 
very hard to work with, poor OH, 
gingivitis 
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a = CH placebo used for refined analysis
 
b = 0.12% CH used for refined analysis
 
m = mechanical treatment between check up
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 Subjects
 
Number 

1
 
2
 
3a
 
4
 
5
 
ea
 
7b
 
8
 
9b
 
10*5
 
11
 
12
 
13
 
14m
 
15
 
16^m
 
Sex
 
F
 
F
 
F
 
F
 
F
 
F
 
F
 
F
 
F
 
F
 
F
 
M
 
M
 
MUL CARE
 
Characteristics
 
Good oral hygiene, great patient,
 
cooperative
 
Nice patient, good OH, cooperative
 
Good OH, nice patient, cooperative
 
cooperative, good OH, good patient
 
Good OH, great patient, cooperative
 
Good OH, cooperative, nice patient
 
Fair OH, good patient, cooperative
 
Fair OH, sick in the 1st month,
 
cooperative
 
Fair OH, good patient, cooperative,
 
gingivitis
 
Mental problems, sometimes cooperative,
 
fair OH
 
Mental problems, good oral hygiene,
 
cooperative
 
Fair OH, good patient, cooperative
 
Fair OH, sick in the 1st month,
 
cooperative
 
Poor OH, confused, cooperative, good
 
patient, gingivitis
 
Physical disability, poor OH, Spanish
 
speaking, cooperative, nice patient
 
Very poor OH, uncooperative, sick all
 
the time, very hard to work with,
 
gingivitis
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DEL ROSA
 
Subjects	 Characteristics
 
Number Sex
 
lb F	 Good oral hygiene, super patient,
 
cooperative
 
2 F	 Good OH, nice patient, cooperative
 
3^ M	 Good OH, great patient, cooperative
 
4b
 M	 Nice patient, good OH, cooperative
 
5a
 F	 Good OH, after a bad stroke in the 1st
 
month only, fair OH, great patient,
 
cooperative
 
6b F	 Good OH, confused, nice patient,
 
cooperative
 
7a F	 Fair OH, cooperative, good patient
 
gb F	 Mild mental problems, fair OH,
 
cooperative
 
9a F	 Fair OH, good patient, sometimes
 
cooperative
 
lob M	 Mental and physical disabilities, nice
 
patient, uncooperative sometimes, fair
 
OH
 
lib F	 Mild mental problems, fair OH,
 
cooperative
 
12m F	 Fair OH, sick in the 1st month,
 
cooperative
 
13^m M	 Poor OH, good patient, cooperative
 
a = CH placebo used for refined analysis
 
b = 0.12% CH used for refined analysis
 
m= mechanical treatment between check up
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